| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Chief Accounting Officer
1 company
Megna Michael R is a Chief Accounting Officer at Kiniksa Pharmaceuticals International, plc. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $2.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 50,490 | $38.87 | $1,962,781.45 | -42.9% | +5.2% | - | |
| Sep 3, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 11,000 | $34.84 | $383,240.00 | -22.4% | +12.9% | - | |
| Aug 4, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 17,000 | $32.35 | $549,950.00 | -34.0% | +13.7% | - | |
| Jun 3, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 15,211 | $28.75 | $437,316.25 | -31.9% | +17.8% | - | |
| May 7, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 17,647 | $26.69 | $470,998.43 | -35.2% | +23.5% | - | |
| Mar 12, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 9,051 | $22.45 | $203,194.95 | -25.4% | +32.3% | +104.8% | |
| Nov 29, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 8,646 | $22.45 | $194,102.70 | -14.0% | -11.1% | +92.6% | |
| Mar 1, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 14,785 | $21.57 | $318,881.09 | -29.6% | -14.6% | -6.7% | |
| Jan 2, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 16,670 | $19.17 | $319,563.90 | -49.5% | +6.3% | +7.6% | |
| Dec 19, 2023 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Accounting Officer | Sale+OE | 9,316 | $19.13 | $178,215.08 | -35.4% | +2.7% | +5.2% |